Queen's fertility expert wins international award

December 16, 2013

A Queen's University Professor has received international recognition for her research into male infertility.

Professor Sheena Lewis fought off competition from more than 70 innovators, researchers and business women from across Europe to win the Gold Award for Innovation at the European Women Inventors & Innovators Network (EUWIIN) awards last week in Stockholm.

The award also means that the next EUWINN event in 2015 is likely to be in Professor Lewis' home city of Belfast.

EUWIN was launched at the European Parliament in 2006. Since then EUWIIN winners have been entrepreneurs, scientists, engineers, technologists or designers from all sectors across Europe and beyond. Each winner has created a new device or system or process capable of impacting millions of people for the better.

Professor Sheena Lewis, from the School of Medicine, Dentistry and Biomedical Sciences at Queen's, said: "I am delighted and honoured to have won the gold award for innovation at the European Women Inventors & Innovators Network awards. It is great to have my work recognised at an international level by such a prestigious award. It is testimony to the high level of research being undertaken at Queen's University and the opportunity to translate this research into the benefit of society as we have been able to do through Queen's spin out Lewis Fertility Testing Ltd with the help of our business hub QUBIS."

Diane Morris, Chair of the EUWIIN Judging Panel, said: "The EUWIIN Judging panel, who represented different countries and professional expertise reviewed over 70 nominations, were impressed by Professor Lewis' research and her enthusiasm for it's potential." The Sperm Comet test, developed in 2011 is a ground-breaking test for male infertility, which saves time, money and heartache for couples around the world.

The SpermComet provides unique information that no other test offers. By measuring damaged DNA in individual sperm, it can predict the success of infertility treatments and fast-track couples to the treatment most likely to succeed, leading to significantly reduced waiting times and improved chances of conception.
For further information on Professor Lewis' work visit: http://lewisfertilitytesting.com/

Media inquiries to Claire O'Callaghan, Queen's University Communications Office, Tel: +44 (0)28 9097 5391 email: c.ocallaghan@qub.ac.uk

Notes to Editors:

Professor Sheena Lewis is available for interview. Interview bids to Claire O'Callaghan in the Queen's University Communications

Queen's University Belfast

Related Male Infertility Articles from Brightsurf:

Delivering proteins to testes could someday treat male infertility
According to the Mayo Clinic, about 15% of couples are infertile, and male infertility plays a role in over one-third of these cases.

A critical enzyme for sperm formation could be a target for treating male infertility
Researchers led by Jeremy Wang of the University of Pennsylvania School of Veterinary Medicine have identified an enzyme essential for the process of male meiosis, the type of cell division that produces sperm.

Discovery of genes involved in infertility
A research group from Kumamoto University, Japan has discovered a gene, 'Meiosin', that acts as the switch to turn on meiosis.

Trial examines effect of folic acid, zinc supplementation in male partners of couples seeking infertility treatment
This randomized clinical trial examined the effects of daily folic acid and zinc supplementation in men on semen quality and live births among 2,300 couples planning infertility treatment.

New gene for male infertility discovered
Investigators have found that a genetic rearrangement and variants affecting a gene known as SYCP2 are associated with low sperm count and report the first cases implicating the gene in four men with infertility.

Penn researchers uncover defective sperm epigenome that leads to male infertility
One out of eight couples has trouble conceiving, with a quarter of those cases caused by unexplained male infertility.

A potential new way to diagnose male infertility and pharmaceutical treatment options
Washington State University-led research has discovered infertile men have identifiable patterns of epigenetic molecules or biomarkers attached to their sperm DNA that aren't present in fertile men.

Chlamydia in testicular tissue linked to male infertility
The potential impact of undiagnosed sexually transmitted chlamydia infection on men's fertility has been highlighted in a study led by scientists at Queensland University of Technology (QUT), which for the first time found chlamydia in the testicular tissue biopsies of infertile men whose infertility had no identified cause.

ICSI has no outcome benefits over conventional IVF in routine non-male infertility cases
Intracytoplasmic sperm injection (ICSI), the world's favored means of fertilization in assisted reproduction, offers no benefit over conventional in vitro fertilization in fertility treatments without a male factor indication, according to results of a large multicenter study.

The FASEB Journal: DNA repair gene linked to male infertility
A key DNA repair gene known as X-ray repair cross-complementing group 1, or XRCC1, plays a vital role in maintaining genomic stability and is highly expressed in the early stages of sperm cell development (also known as spermatogenesis).

Read More: Male Infertility News and Male Infertility Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.